TY  - CHAP
M1  - Book, Section
TI  - Secondary Amenorrhea & Menopause
A1  - Fitzgerald, Paul A.
A2  - Papadakis, Maxine A.
A2  - McPhee, Stephen J.
A2  - Rabow, Michael W.
PY  - 2021
T2  - Current Medical Diagnosis & Treatment 2021
AB  - Key  Clinical  Updates  in  Secondary  Amenorrhea  &  MenopauseParoxetine  is  FDA-approved  for  treatment  of  vasomotor  symptoms  but  it  is  not  recommended  for  women  taking  tamoxifen,  since  it  reduces  the  conversion  of  tamoxifen  to  its  active  metabolite.  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2022/01/19
UR  - accessmedicine.mhmedical.com/content.aspx?aid=1175787153
ER  -